2025-07-29 - Analysis Report
Okay, here's the analysis of Transmedics Group Inc (TMDX) based on the provided data, formatted as a concise English report.

**Transmedics Group Inc (TMDX) Analysis Report**

Transmedics Group Inc is a medical technology company focused on developing and delivering innovative organ preservation systems for transplantation therapy.

**1. Performance vs. S&P 500 (VOO)**

*   **TMDX Cumulative Return:** 224.42%
*   **VOO Cumulative Return:** 71.20%
*   **Absolute Divergence:** 155.4 (Max: 296.4, Min: -64.2)
*   **Relative Divergence:** 60.9

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO). The absolute divergence indicates a substantial lead in cumulative returns. The relative divergence of 60.9 suggests that the current divergence is above the median of its historical range, indicating strong relative performance.

**Alpha/Beta Analysis Table**

| Year        | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
| ----------- | ------- | ------- | ------- | ------ | ------ |
| 2019-2021   | -4.0%   | 63.4%   | -52.0%  | 0.0    | 0.7    |
| 2020-2022   | 140.0%  | 68.3%   | 138.0%  | 0.1    | 2.1    |
| 2021-2023   | 95.0%   | 69.4%   | 77.0%   | 0.2    | 2.7    |
| 2022-2024   | 147.0%  | 82.8%   | 121.0%  | 0.2    | 2.1    |
| 2023-2025   | 106.0%  | 82.8%   | 54.0%   | 0.5    | 3.6    |

**Analysis:**

*   **CAGR:** Shows high growth rates in recent years, indicating strong performance, although there was a significant drop in 2019-2021.
*   **MDD:** Consistently high Maximum Drawdown (MDD) values point to significant volatility and risk.
*   **Alpha:** High positive Alpha values suggest TMDX is generating returns above what would be expected based on market movements.
*   **Beta:** The low Beta values generally indicate that the stock's returns have been less sensitive to the market (S&P 500) movements. However, Beta has increased significantly from 0.1 to 0.5 in the latest period, meaning recently Transmedics Group Inc is more sensitive to market

**2. Recent Price Action**

*   **Current Price:** $105.24
*   **Previous Close:** $108.12
*   **Change:** -2.66
*   **5-Day Moving Average:** $107.14
*   **20-Day Moving Average:** $117.04
*   **60-Day Moving Average:** $121.39

**Analysis:**  The stock price has recently decreased. The current price is below all moving averages, indicating a potential downtrend. The negative change from the previous close suggests immediate selling pressure.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3286 (Low Risk)
*   **RSI:** 29.30 (Oversold)
*   **PPO:** -1.07
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35)
*   **Recent Relative Divergence Change (20-day):** -1.2 (Negative - Short-term decline)
*   **Expected Return:** 62.5%

**Analysis:**

*   The MRI indicates low market risk overall.
*   An RSI below 30 suggests the stock is oversold, which *could* indicate a potential rebound (but doesn't guarantee it).
*   The negative PPO reinforces the downtrend signal.
*   The hybrid signal recommends selling a small portion of holdings and increasing cash position, showing short-term bearish sentiment. The large negative change reflects the recent price drop.
*   Expected Return: A 62.5% expected return suggests a potentially favorable long-term outlook compared to the S&P 500.

**4. Recent News & Significant Events**

*   Recent news points to major business developments, regulatory changes, and market events impacting TMDX.
*   Analysts are discussing TMDX's recent performance in the context of industry trends and global economic factors.
*   The stock has shown notable volatility.
*   Market experts highlight both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** The news indicates significant activity and market attention surrounding TMDX, but also highlights volatility and the need for caution.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 예상 EPS |
| ----------- | ----- | ------- |
| 2025-05-08  | 0.7   | 0.29    |
| 2025-02-27  | 0.19  | 0.22    |
| 2024-10-28  | 0.12  | 0.29    |
| 2024-07-31  | 0.35  | 0.21    |
| 2024-04-30  | 0.35  | 0.03256 |

**Analysis:** TMDX has generally exceeded EPS estimates in recent quarters. The significant beat in 2025-05-08 suggests strong recent performance. The previous earnings show exceeded EPS.

**6. Financial Information**

| Quarter    | Revenue | Profit Margin |
| ----------- | ------- | ------------- |
| 2025-03-31  | $0.14B | 61.47%        |
| 2024-12-31  | $0.12B | 59.21%        |
| 2024-09-30  | $0.11B | 55.94%        |
| 2024-06-30  | $0.11B | 60.59%        |
| 2024-03-31  | $0.10B | 61.91%        |

| Quarter    | Equity   | ROE    |
| ----------- | -------- | ------ |
| 2025-03-31  | $0.27B  | 9.64%  |
| 2024-12-31  | $0.23B  | 3.00%  |
| 2024-09-30  | $0.21B  | 2.01%  |
| 2024-06-30  | $0.19B  | 6.42%  |
| 2024-03-31  | $0.16B  | 7.65%  |

**Analysis:**

*   **Revenue:** Revenue has been consistently increasing, demonstrating growth.
*   **Profit Margin:** High and stable profit margins indicate strong profitability.
*   **Equity:** Increasing equity reflects positive growth.
*   **ROE:** ROE has been volatile, but the most recent quarter shows a significant increase, suggesting improved profitability relative to equity.

**7. Overall Assessment**

TMDX has demonstrated significant outperformance relative to the S&P 500, driven by high growth and strong profitability. Recent earnings have exceeded expectations. However, the stock exhibits high volatility (high MDD) and has experienced a recent price decline, leading to oversold conditions and a sell signal from the hybrid indicator.  The MRI suggests low overall market risk, and the strong financial metrics (rising revenue, high profit margins, increasing equity) point to underlying strength. The long-term expected return remains attractive. Investors should carefully monitor news, announcements, and market conditions given the stock's volatility. The increasing Beta also means it's becoming more influenced by general market conditions.
